Testing effectiveness (Phase 2)Study completedNCT01929980
What this trial is testing
Bortezomib to Treat Significant Complication of HSCT
Who this might be right for
Allogeneic Stem Cell TransplantationRefractory Autoimmune Cytopenia(s)
Children's Hospital Medical Center, Cincinnati 4